Caplin Point Laboratories · NSE: CAPLIPOINT · BSE: 524742
Q2 FY23 results · Jul–Sep 2022
Caplin Point Laboratories reported revenue from operations of ₹359.05 crore (up 18.3% from Q2 FY22) and net profit of ₹92.03 crore (up 19.8% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 359.05 | 303.53 | +18.3% | 346.33 | +3.7% |
| Other income | 16.48 | 8.49 | +94.1% | 13.94 | +18.2% |
| Total income | 375.53 | 312.02 | +20.4% | 360.27 | +4.2% |
| Profit before tax | 110.45 | 97.73 | +13.0% | 105.09 | +5.1% |
| Net profit for the period | 92.03 | 76.82 | +19.8% | 86.31 | +6.6% |
| Attributable to shareholders of the company | 91.67 | — | — | 84.99 | +7.9% |
| EPS, basic (₹) | 12.09 | 9.91 | +22.0% | 11.21 | +7.9% |
| Net margin (%) | 25.6 | 25.3 | 24.9 |
| Item | Q2 FY23 | Q2 FY22 | YoY | Q1 FY23 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 136.95 | 160.40 | −14.6% | 116.39 | +17.7% |
| Other income | 22.45 | 18.42 | +21.9% | 34.97 | −35.8% |
| Total income | 159.40 | 178.82 | −10.9% | 151.36 | +5.3% |
| Profit before tax | 73.32 | 83.49 | −12.2% | 74.70 | −1.8% |
| Net profit for the period | 57.51 | 65.16 | −11.7% | 63.24 | −9.1% |
| EPS, basic (₹) | 7.59 | 8.61 | −11.8% | 8.34 | −9.0% |
| Net margin (%) | 42.0 | 40.6 | 54.3 |
Consolidated
- Filed with BSE
- 13 Nov 2022, 13:50 IST
- Board meeting
- 12 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Nov 2022, 13:50 IST
- Board meeting
- 12 Nov 2022
- Period
- 01 Jul 2022 to 30 Sep 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE